These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8740235)

  • 21. Mitochondrial pathology in inclusion body myositis.
    Lindgren U; Roos S; Hedberg Oldfors C; Moslemi AR; Lindberg C; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):281-8. PubMed ID: 25638290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological data in inflammatory myositis].
    Mikol J; Polivka M
    Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological and biochemical assessment of mitochondrial function in dermatomyositis.
    Miró O; Casademont J; Grau JM; Jarreta D; Urbano-Márquez A; Cardellach F
    Br J Rheumatol; 1998 Oct; 37(10):1047-53. PubMed ID: 9825742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
    Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
    Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
    [No Abstract]   [Full Text] [Related]  

  • 27. Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
    Schoser BG; Blottner D; Stuerenburg HJ
    Acta Neurol Scand; 2002 Apr; 105(4):309-13. PubMed ID: 11939944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
    De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
    Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy.
    Blume G; Pestronk A; Frank B; Johns DR
    Brain; 1997 Jan; 120 ( Pt 1)():39-45. PubMed ID: 9055796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
    De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
    Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of inflammatory myopathies.
    Del Grande F; Carrino JA; Del Grande M; Mammen AL; Christopher Stine L
    Top Magn Reson Imaging; 2011 Apr; 22(2):39-43. PubMed ID: 22648079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
    Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
    Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.
    De Bleecker JL; Meire VI; Declercq W; Van Aken EH
    Neuromuscul Disord; 1999 Jun; 9(4):239-46. PubMed ID: 10399751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myositides].
    Bornemann A; Heitmann S; Lindner A
    Pathologe; 2009 Sep; 30(5):352-6. PubMed ID: 19618187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion.
    Hedberg-Oldfors C; Lindgren U; Visuttijai K; Lööf D; Roos S; Thomsen C; Oldfors A
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12841. PubMed ID: 35894812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology.
    Alhatou MI; Sladky JT; Bagasra O; Glass JD
    J Mol Histol; 2004 Aug; 35(6):615-9. PubMed ID: 15614615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.